메뉴 건너뛰기




Volumn 29, Issue 38, 2011, Pages 6441-6442

Free school-based vaccination with HPV vaccine in a Japanese city

Author keywords

Cervical cancer; Human papillomavirus; School based vaccination

Indexed keywords

WART VIRUS VACCINE;

EID: 80051672737     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.031     Document Type: Letter
Times cited : (3)

References (5)
  • 2
    • 67651049056 scopus 로고    scopus 로고
    • Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
    • Paavonen J., Naud P., Salmerón J., Wheeler C.M., Chow S.N., Apter D., et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374:301-314.
    • (2009) Lancet , vol.374 , pp. 301-314
    • Paavonen, J.1    Naud, P.2    Salmerón, J.3    Wheeler, C.M.4    Chow, S.N.5    Apter, D.6
  • 3
    • 71649087760 scopus 로고    scopus 로고
    • Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years
    • GlaxoSmithKline Vaccine HPV-007 Study Group
    • GlaxoSmithKline Vaccine HPV-007 Study Group, Romanowski B., de Borba P.C., Naud P.S., Roteli-Martins C.M., De Carvalho N.S., et al. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 2009, 374:1975-1985.
    • (2009) Lancet , vol.374 , pp. 1975-1985
    • Romanowski, B.1    de Borba, P.C.2    Naud, P.S.3    Roteli-Martins, C.M.4    De Carvalho, N.S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.